Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors.

Pastori S, Virzì GM, Brocca A, de Cal M, Clementi A, Vescovo G, Ronco C.

Cardiorenal Med. 2015 Apr;5(2):105-15. doi: 10.1159/000371898. Epub 2015 Feb 11.

2.

Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis.

Virzì GM, Clementi A, de Cal M, Brocca A, Day S, Pastori S, Bolin C, Vescovo G, Ronco C.

Oxid Med Cell Longev. 2015;2015:391790. doi: 10.1155/2015/391790. Epub 2015 Mar 4.

3.

Advances in the pathogenesis of cardiorenal syndrome type 3.

Clementi A, Virzì GM, Brocca A, de Cal M, Pastori S, Clementi M, Granata A, Vescovo G, Ronco C.

Oxid Med Cell Longev. 2015;2015:148082. doi: 10.1155/2015/148082. Epub 2015 Mar 4. Review.

4.

Pain management in internal medicine and effects of a standardised educational intervention: the FADOI-DOMINO study.

Civardi G, Zucco F, Valerio A, Fontanella A, Alessandri M, Ciannamea CD, Perale L, Gussoni G, Bonizzoni E, Vescovo G, Agnelli G, Campanini M, Mazzone A, Nozzoli C; Research Department of FADOI.

Int J Clin Pract. 2015 Jan;69(1):33-40. doi: 10.1111/ijcp.12515. Epub 2014 Oct 6.

PMID:
25283604
5.

The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.

Virzì GM, Clementi A, Brocca A, de Cal M, Vescovo G, Granata A, Ronco C.

Cardiorenal Med. 2014 Aug;4(2):103-12. doi: 10.1159/000362650. Epub 2014 May 14. Review.

6.

(99m)Tc-DTPA scintigraphy assesses the absence of glomerular filtration rate impairment of Aliskiren in high-risk hypertensive subjects. A 12-month follow-up study.

Mazza A, Montemurro D, Maffione AM, Vescovo G, Rampin L, Zuin M, Schiavon L, Camerotto A, Marzola MC, Fiorini F, Rubello D.

Minerva Cardioangiol. 2014 Aug;62(4):311-20.

PMID:
25012100
7.

Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.

Berisso MZ, Fabbri G, Gonzini L, Caruso D, Fontanella A, Pellegrini F, Silvestri N, Vincenti A, Mathieu G, Di Pasquale G; ATA-AF Investigators.

J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):626-35. doi: 10.2459/JCM.0000000000000110.

PMID:
24978662
8.

Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone.

Pesavento R, Filippi L, Pagnan A, Visonà A, Pauletto P, Vescovo G, Cuppini S, Beltramello G, Villalta S, De Conti G, Vedovetto V, Frigo AC, Prandoni P; PROVE Investigators Group.

Am J Respir Crit Care Med. 2014 May 15;189(10):1277-9. doi: 10.1164/rccm.201312-2251LE. No abstract available.

PMID:
24832746
9.

[Definition of acute heart failure].

Metra M, Carbone G, Lombardi C, Borghi C, Vescovo G.

G Ital Cardiol (Rome). 2014 Feb;15(2 Suppl 2):5S-9S. doi: 10.1714/1465.16181. Italian.

PMID:
24770483
10.

Cardiorenal syndrome type 4: management.

Clementi A, Virzì GM, Brocca A, de Cal M, Vescovo G, Granata A, Ronco C.

Blood Purif. 2013;36(3-4):200-9. doi: 10.1159/000356369. Epub 2013 Dec 20. Review.

11.

Heart-kidney crosstalk and role of humoral signaling in critical illness.

Virzì G, Day S, de Cal M, Vescovo G, Ronco C.

Crit Care. 2014 Jan 6;18(1):201. doi: 10.1186/cc13177.

12.

Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2bPILOT Study.

Mazzone A, Di Salvo M, Mazzuca S, Valerio A, Gussoni G, Bonizzoni E, Campanini M, Vescovo G, Nozzoli C; FADOI 2bPILOT Study Group.

Eur J Clin Invest. 2013 Nov;43(11):1163-70. doi: 10.1111/eci.12159. Epub 2013 Sep 17.

PMID:
24102344
13.

Cardiorenal syndrome type 4: a review.

Clementi A, Virzì GM, Goh CY, Cruz DN, Granata A, Vescovo G, Ronco C.

Cardiorenal Med. 2013 Apr;3(1):63-70. doi: 10.1159/000350397.

14.

Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.

Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, Vescovo G, Zuin M, Chondrogiannis S, Ravenni R, Opocher G, Colletti PM, Rubello D.

Endocrine. 2014 Apr;45(3):469-78. doi: 10.1007/s12020-013-0007-y. Epub 2013 Jul 2. Review.

PMID:
23817839
15.

Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Cruz DN, Schmidt-Ott KM, Vescovo G, House AA, Kellum JA, Ronco C, McCullough PA.

Contrib Nephrol. 2013;182:117-36. doi: 10.1159/000349968. Epub 2013 May 13.

16.

Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, Cruz D, House AA, Schmidt-Ott KM, Vescovo G, Bagshaw SM, Hoste EA, Briguori C, Braam B, Chawla LS, Costanzo MR, Tumlin JA, Herzog CA, Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C.

Contrib Nephrol. 2013;182:82-98. doi: 10.1159/000349966. Epub 2013 May 13.

PMID:
23689657
17.

Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.

Gussoni G, Di Pasquale G, Vescovo G, Gulizia M, Mathieu G, Scherillo M, Panuccio D, Lucci D, Nozzoli C, Fabbri G, Colombo F, Riva L, Baldo CI, Maggioni AP, Mazzone A; ATA-AF Steering Committee and Investigators.

Eur J Intern Med. 2013 Jun;24(4):324-32. doi: 10.1016/j.ejim.2013.04.008. Epub 2013 May 16.

PMID:
23684591
18.

Medical professional values and education: a survey on italian students of the medical doctor school in medicine and surgery.

Montemurro D, Vescovo G, Negrello M, Frigo AC, Cirillo T, Picardi E, Chiminazzo C, El Mazloum D, De Caro R, Benato M, Ferretti A, Mazza A, Marcolongo A, Rubello D.

N Am J Med Sci. 2013 Feb;5(2):134-9. doi: 10.4103/1947-2714.107535.

19.

The contribution of stem cell therapy to skeletal muscle remodeling in heart failure.

Castellani C, Vescovo G, Ravara B, Franzin C, Pozzobon M, Tavano R, Gorza L, Papini E, Vettor R, De Coppi P, Thiene G, Angelini A.

Int J Cardiol. 2013 Oct 3;168(3):2014-21. doi: 10.1016/j.ijcard.2013.01.168. Epub 2013 Feb 28.

PMID:
23453873
20.

[Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms].

Virzi' GM, de Cal M, Cruz DN, Bolin C, Vescovo G, Ronco C.

G Ital Nefrol. 2012 Nov-Dec;29(6):690-8. Italian.

PMID:
23229667
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk